ADC Therapeutics SA – Trademark Portfolio
Entity Type: 99
ADC Therapeutics SA holds 35 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 30 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 8 trademarks are registered and 3 are pending. Notable registered marks include ZYNLONTA and ADC THERAPEUTICS. The owner is based in Epalinges.
Route de la Corniche 3B
Epalinges 1066 , CH
Showing of trademarks Trademarks
Trademark Classifications
ADC Therapeutics SA's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does ADC Therapeutics SA have?
ADC Therapeutics SA has 35 U.S. trademarks filed with the USPTO. Of these, 8 registered, 3 pending, 23 abandoned, 1 cancelled.
What trademark classes does ADC Therapeutics SA file in?
ADC Therapeutics SA files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ADC Therapeutics SA's most well-known trademarks?
ADC Therapeutics SA's registered trademark portfolio includes well-known marks such as ZYNLONTA and ADC THERAPEUTICS. These are among 8 currently registered trademarks in the portfolio.
What is ADC Therapeutics SA's trademark registration success rate?
ADC Therapeutics SA has a 25% trademark registration rate, with 8 out of 32 resolved applications resulting in successful registration. Currently, 3 applications are pending review.